Julio Schwarz, MD
Cardiovascular Disease · Fort Smith, ARNPI 1699779314
Payments from drug & device makers
Across 425 payments — averaging $164.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$28K
- Amgen$26K
- Amarin Pharma, Inc.$6K
- Boehringer Ingelheim$6K
- Johnson & Johnson$907
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$599
- plus $2K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 58 | $27,637 |
| Amgen | 109 | $26,261 |
| Amarin Pharma, Inc. | 9 | $6,285 |
| Boehringer Ingelheim | 32 | $6,257 |
| Johnson & Johnson | 69 | $907 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 45 | $599 |
| Merck | 24 | $410 |
| Medtronic(2 entities) | 15 | $227 |
| Regeneron Healthcare Solutions, Inc. | 6 | $184 |
| AstraZeneca | 10 | $160 |
| Pfizer | 12 | $159 |
| E.r. Squibb & Sons, L.L.C. | 8 | $117 |
| Kestra Medical Technology Services, Inc. | 4 | $96 |
| Esperion Therapeutics, Inc. | 4 | $70 |
| Alnylam Pharmaceuticals Inc. | 4 | $68 |
| Bridgebio Pharma, Inc. | 3 | $49 |
| Scpharmaceuticals Inc. | 2 | $37 |
| Bayer | 2 | $32 |
| Philips North America LLC | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Edwards Lifesciences | 1 | $22 |
| Abiomed | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Novo Nordisk | 1 | $20 |
| Biotronik Inc. | 1 | $13 |
How this compares
$69,702 in reported general payments places this provider in the 85th percentile of 130 cardiovascular disease providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Fort Smith
- Abdul-Nasser AdjeiFort Smith$91K
- Robert ParrisFort Smith$13K
- Ian CawichLittle Rock$1.1M
- Christian Assad KottnerLittle Rock$670K
- Barry UretskyLittle Rock$609K
- Maximiliano ArroyoJonesboro$553K
- William RollefsonLittle Rock$512K
- David JonesLittle Rock$473K
- Joe HargroveLittle Rock$464K
- Freddy ChrismanLittle Rock$283K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.